Power Corp Of Canada Gilead Sciences, Inc. Transaction History

Power Corp Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $1.83 Million - $2.07 Million	-24,961 Reduced 34.56%	47,267 $3.83 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $5.49 Million - $6.26 Million	72,228 New	72,228 $5.57 Million
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $5.58 Million - $6.36 Million	72,228 New	72,228 $5.99 Million
Q3 2022 Nov 18, 2022	BUY	$59.54 - $68.01 $1.94 Million - $2.22 Million	32,595 New	32,595 $2.01 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.83 Million - $2.06 Million	-31,755 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.84 Million - $2.3 Million	31,755 New	31,755 $1.89 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Power Corp Of Canada, based on Form 13F filings with the SEC.

Stay updated on Power Corp Of Canada with notifications on news.